MAPT and Alzheimer disease: Although much of what we have learned about AD progression has come from studies focused on the abnormal processing and accumulation of Aβ, the phosphorylation of tau has also been shown to be a key player in disease pathogenesis, and mounting evidence suggests that there may be a synergistic interaction between Aβ42 and tau (reviewed in Busche and Hyman 2020).